Delivery Order SPE2DB25D3012-SPE2DB25FWYNT
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $36,199.65 and is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML medical products. The contract is a firm fixed-price delivery order, with a period of performance running through February 10, 2025. AmerisourceBergen is the prime contractor on...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a pharmaceutical product, BIMZELX 320 MG/2 ML AUTOINJECT 2ML, with a ceiling value of $16,658.59 and a performance period through May 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of BIMZELX 320 MG/2 ML AUTOINJECT 2ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price, non-set-aside agreement with a ceiling value of $13,795.65 and a period of performance through June 10, 2025. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,791.12, is for the supply of BIMZELX 160 MG/ML AUTOINJECTOR ML, a specialty medication. The contract has a firm fixed-price pricing structure and an ultimate completion date of October 11, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product, with a ceiling value of $124,433.09. The contract has a firm fixed price pricing type and an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BIMZELX 320 MG/2 ML AUTOINJECT 2ML, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $15,507.35, and a period of performance through July 9, 2025. This award is not designated as a set-aside contract, indicating open competition....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,917.07, is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,374.03, is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 18, 2025 and is a firm fixed-price contract. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $34,329.15 firm fixed-price contract is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product, with a period of performance through January 16, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BIMZELX 320 MG/2 ML AUTOINJECT 2ML. The contract has a firm fixed price with a ceiling value of $9,855.21 and a period of performance through July 10, 2025. Amerisourcebergen Drug Corp is a for-profit organization that holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYNTDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIMZELX 320 MG/2 ML AUTOINJECT 2ML medical products, with a ceiling value of $29,565.63 and a performance period ending on July 14, 2025. The contract is not set-aside and was awarded on a firm fixed-price basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely a task order issued under that larger IDC, enabling Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.6k | 7/11/25 |